Clinical Trials Directory

Trials / Completed

CompletedNCT03015857

Phenylephrine and Noradrenaline for Post Spinal Anesthesia Hypotension

A Comparison Between Phenylephrine and Norepinephrine Boluses in Prevention of Post-spinal Hypotension During Cesarean Delivery

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Kasr El Aini Hospital · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

Hypotension following spinal anesthesia for cesarean section is a serious problem. In this study we investigated the effect of the vasopressors phenylephrine and noradrenaline on postspinal hypotension.

Detailed description

On arrival to the operating room, an 18g cannula will be inserted and monitors will be applied (electrocardiography - pulse oximetry - non-invasive blood pressure monitor). Patients will receive spinal anesthesia with 500 ml rapid crystalloid co-load. Ten milligrams heavy bupivacaine in addition to 20 mcg fentanyl will be injected in L3-L4 or L4-L5 interspace using 25 g spinal needle in the sitting position. After spinal block, patients will be randomly allocated into one of two groups: * Phenylephrine group (n=100) * Norepinephrine group (n=100) Patients who shows SBP above 140 mmHg or heart rate below 55 bpm after the first vasopressor dose will not receive the infusion. The infusion will stop if the SBP was above 140 mmHg or if the heart rate was below 55 bpm. Patients will be positioned in the supine position with left lateral tilt. Block success will be assessed using pinprick, patients with failed block will be excluded from the study. The highest sensory block level will be assessed after 5 minutes from intrathecal injection. Co-hydration will be continued till maximum of 1.5 litres.

Conditions

Interventions

TypeNameDescription
DRUGphenylephrine\- phenylephrine; a vasopressor drug given to prevent post spinal hypotension
DRUGNorepinephrine\- norepinephrine; a vasopressor drug given to prevent post spinal hypotension
DRUGBupivacaineintrathecal bupivacaine 10 mg will be given in both groups
DRUGFentanylintrathecal fentanyl 20 mcg will be given in both groups
DRUGPlacebo (normal saline)

Timeline

Start date
2017-01-01
Primary completion
2017-03-01
Completion
2017-04-01
First posted
2017-01-10
Last updated
2017-05-03

Source: ClinicalTrials.gov record NCT03015857. Inclusion in this directory is not an endorsement.